results
Jump to
6 Results Found
  • Expect revenue of around Rs 400 cr in Q4: Shasun Pharma Feb 10, 2014 03:44 PM IST

    Expect revenue of around Rs 400 cr in Q4: Shasun Pharma

    Abhaya Kumar of Shasun Pharma believes Q4 is always a better quarter and hopes to maintain revenue growth and EBITDA at around current levels.

  • Find out: FMCG, pharma, Oil& Gas who will lead Q4 earnings? Apr 11, 2013 04:38 PM IST

    Find out: FMCG, pharma, Oil& Gas who will lead Q4 earnings?

    The fourth quarter earnings will begin from Friday. In an interview to CNBC-TV18, Varatharajan Sivasankaran of ICICI Securities outlined his expectations from stocks across various sectors.

  • Sun Pharma to continue holding stake in Taro, says VP Fin Feb 12, 2013 10:57 AM IST

    Sun Pharma to continue holding stake in Taro, says VP Fin

    Uday Baldota, Senior Vice President-Finance & Accounts, Sun Pharma said the company will continue to hold stake in Taro despite their termination of the merger agreement.

  • Shasun Pharma eyes robust Q4 growth, says MD Feb 08, 2013 11:14 AM IST

    Shasun Pharma eyes robust Q4 growth, says MD

    Abhaya Kumar, MD of Shasun Pharmaceuticals said the Q3 margins were stressed owing to price pressures from the US.

  • Growth in margins sustainable going forward: Shasun Pharma Feb 10, 2012 03:43 PM IST

    Growth in margins sustainable going forward: Shasun Pharma

    Abhaya Kumar, managing director of Shasun Pharmaceuticals, tells CNBC-TV18 that the jump in margins is sustainable going ahead.

  • Merck JV will earn revenues in a few years, says Sun Pharma May 30, 2011 04:48 PM IST

    Merck JV will earn revenues in a few years, says Sun Pharma

    In an exclusive interview with CNBC-TV18, Uday Baldota of Sun Pharma says the company saw significant growth in Sun Pharma’s standalone numbers, while as well "Taro reported strong margins this quarter." The leading drugmaker discloses that the company is "bearing additional costs for some non-revenue generating businesses."

Sections